Fauna asociada a la palma de vino Attalea butyracea (Mutis ex L.f.) Wess.Boer (1988) (Arecales: Arecaceae) en un agroecosistema de Galeras, Sucre, Colombia

The fauna associated with Attalea butyracea was studied in an agroecosystem of Galeras, Sucre, Colombia. Samplings were carried out during June 2016 in the farm Mi Ranchito, where 42 palms were checked. From the palms, arthropods were extracted and vertebrates were searched for. Subsequently, the material was identified and 13 orders were recorded with appearance frequencies and abundances as follows: Hymenoptera (100%; 232), Coleoptera (97.62%; 240), Araneae (95.24%; 169), Blattodea (88.09%; 143), Hemiptera (88.09%; 82), Amblypygi (85.71%; 166), Polydesmida (78.57%; 103), Lepidoptera (73.81%; 69), Archaeognatha (71.43%; 81), Orthoptera (69.04%; 31), Scorpiones (69.04%; 30), Ixodida (66.66%; 34) and Opiliones (66.66%; 57). Eighteen species were identified as follows: Arachnida: Charinus sp., Hapalopus sp., Phrynus barbadensis and Tityus tayrona; Insecta: Phileurus sp., Rhodnius pallescens and Triatoma dimidiata; Amphibia: Elachistocleis pearsei and Rhinella humboldti; Sauropsida: Bothrops asper, Cnemidophorus lemniscatus, Gonatodes albogularis, Gymnophthalmus speciosus and Mabuya sp.; and Mammalia: Artibeus lituratus, Didelphis marsupialis, Molossus sp. and Mus musculus. In conclusion, the Wine Palm functions as a microenvironment for arthropods and small vertebrates due to its architecture; it is used as a dwelling, dormitory or occasional refuge, making it an important site for interactions of wild animals.Se estudió la fauna asociada a Attalea butyracea en un agroecosistema de Galeras, Sucre, Colombia. Se efectuaron muestreos en junio de 2016 en la nca Mi Ranchito, donde se revisaron 42 palmas. De las palmas se extrajeron artrópodos y se buscaron vertebrados. Posteriormente, el material se identi có y se registraron 13 órdenes, con las siguientes frecuencias de aparición y abundancias: Hymenoptera (100 %; 232), Coleoptera (97,62 %; 240), Araneae (95,24 %; 169), Blattodea (88,09 %; 143), Hemiptera (88,09 %; 82), Amblypygi (85,71 %; 166), Polydesmida (78,57 %; 103), Lepidoptera (73,81 %; 69), Archaeognatha (71,43 %; 81), Orthoptera (69,04 %; 31), Scorpiones (69,04 %; 30), Ixodida (66,66 %; 34) y Opiliones (66,66 %; 57). Se identi caron las siguientes 18 especies: Arachnida: Charinus sp., Hapalopus sp., Phrynus barbadensis y Tityus tayrona; Insecta: Phileurus sp., Rhodnius pallescens y Triatoma dimidiata; Amphibia: Elachistocleis pearsei y Rhinella humboldti; Sauropsida: Bothrops asper, Cnemidophorus lemniscatus, Gonatodes albogularis, Gymnophthalmus speciosus y Mabuya sp.; y Mammalia: Artibeus lituratus, Didelphis marsupialis, Molossus sp. y Mus musculus. En conclusión, la palma de vino, por su arquitectura, funciona como microambiente para artrópodos y vertebrados pequeños; es utilizada como vivienda, dormitorio o refugio ocasional, lo que hace de esta planta un sitio importante en las interacciones de animales silvestres

Fauna asociada a la palma de vino <i>Attalea butyracea</i> (Mutis ex L.f.) Wess.Boer (1988) (Arecales: Arecaceae) en un agroecosistema de Galeras, Sucre, Colombia

Se estudió la fauna asociada a Attalea butyracea en un agroecosistema de Galeras, Sucre, Colombia. Se efectuaron muestreos en junio de 2016 en la nca Mi Ranchito, donde se revisaron 42 palmas. De las palmas se extrajeron artrópodos y se buscaron vertebrados. Posteriormente, el material se identi có y se registraron 13 órdenes, con las siguientes frecuencias de aparición y abundancias: Hymenoptera (100 %; 232), Coleoptera (97,62 %; 240), Araneae (95,24 %; 169), Blattodea (88,09 %; 143), Hemiptera (88,09 %; 82), Amblypygi (85,71 %; 166), Polydesmida (78,57 %; 103), Lepidoptera (73,81 %; 69), Archaeognatha (71,43 %; 81), Orthoptera (69,04 %; 31), Scorpiones (69,04 %; 30), Ixodida (66,66 %; 34) y Opiliones (66,66 %; 57). Se identi caron las siguientes 18 especies: Arachnida: Charinus sp., Hapalopus sp., Phrynus barbadensis y Tityus tayrona; Insecta: Phileurus sp., Rhodnius pallescens y Triatoma dimidiata; Amphibia: Elachistocleis pearsei y Rhinella humboldti; Sauropsida: Bothrops asper, Cnemidophorus lemniscatus, Gonatodes albogularis, Gymnophthalmus speciosus y Mabuya sp.; y Mammalia: Artibeus lituratus, Didelphis marsupialis, Molossus sp. y Mus musculus. En conclusión, la palma de vino, por su arquitectura, funciona como microambiente para artrópodos y vertebrados pequeños; es utilizada como vivienda, dormitorio o refugio ocasional, lo que hace de esta planta un sitio importante en las interacciones de animales silvestres

Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

Objectives: The objective of this study was to estimate the association between tocilizumab or corticosteroids and the risk of intubation or death in patients with coronavirus disease 19 (COVID-19) with a hyperinflammatory state according to clinical and laboratory parameters. Methods: A cohort study was performed in 60 Spanish hospitals including 778 patients with COVID-19 and clinical and laboratory data indicative of a hyperinflammatory state. Treatment was mainly with tocilizumab, an intermediate-high dose of corticosteroids (IHDC), a pulse dose of corticosteroids (PDC), combination therapy, or no treatment. Primary outcome was intubation or death; follow-up was 21 days. Propensity score-adjusted estimations using Cox regression (logistic regression if needed) were calculated. Propensity scores were used as confounders, matching variables and for the inverse probability of treatment weights (IPTWs). Results: In all, 88, 117, 78 and 151 patients treated with tocilizumab, IHDC, PDC, and combination therapy, respectively, were compared with 344 untreated patients. The primary endpoint occurred in 10 (11.4%), 27 (23.1%), 12 (15.4%), 40 (25.6%) and 69 (21.1%), respectively. The IPTW-based hazard ratios (odds ratio for combination therapy) for the primary endpoint were 0.32 (95%CI 0.22-0.47; p < 0.001) for tocilizumab, 0.82 (0.71-1.30; p 0.82) for IHDC, 0.61 (0.43-0.86; p 0.006) for PDC, and 1.17 (0.86-1.58; p 0.30) for combination therapy. Other applications of the propensity score provided similar results, but were not significant for PDC. Tocilizumab was also associated with lower hazard of death alone in IPTW analysis (0.07; 0.02-0.17; p < 0.001). Conclusions: Tocilizumab might be useful in COVID-19 patients with a hyperinflammatory state and should be prioritized for randomized trials in this situatio

Physics case for an LHCb Upgrade II - Opportunities in flavour physics, and beyond, in the HL-LHC era

The LHCb Upgrade II will fully exploit the flavour-physics opportunities of the HL-LHC, and study additional physics topics that take advantage of the forward acceptance of the LHCb spectrometer. The LHCb Upgrade I will begin operation in 2020. Consolidation will occur, and modest enhancements of the Upgrade I detector will be installed, in Long Shutdown 3 of the LHC (2025) and these are discussed here. The main Upgrade II detector will be installed in long shutdown 4 of the LHC (2030) and will build on the strengths of the current LHCb experiment and the Upgrade I. It will operate at a luminosity up to 2×1034 cm−2s−1, ten times that of the Upgrade I detector. New detector components will improve the intrinsic performance of the experiment in certain key areas. An Expression Of Interest proposing Upgrade II was submitted in February 2017. The physics case for the Upgrade II is presented here in more depth. CP-violating phases will be measured with precisions unattainable at any other envisaged facility. The experiment will probe b → sl+l−and b → dl+l− transitions in both muon and electron decays in modes not accessible at Upgrade I. Minimal flavour violation will be tested with a precision measurement of the ratio of B(B0 → μ+μ−)/B(Bs → μ+μ−). Probing charm CP violation at the 10−5 level may result in its long sought discovery. Major advances in hadron spectroscopy will be possible, which will be powerful probes of low energy QCD. Upgrade II potentially will have the highest sensitivity of all the LHC experiments on the Higgs to charm-quark couplings. Generically, the new physics mass scale probed, for fixed couplings, will almost double compared with the pre-HL-LHC era; this extended reach for flavour physics is similar to that which would be achieved by the HE-LHC proposal for the energy frontier

LHCb upgrade software and computing : technical design report

This document reports the Research and Development activities that are carried out in the software and computing domains in view of the upgrade of the LHCb experiment. The implementation of a full software trigger implies major changes in the core software framework, in the event data model, and in the reconstruction algorithms. The increase of the data volumes for both real and simulated datasets requires a corresponding scaling of the distributed computing infrastructure. An implementation plan in both domains is presented, together with a risk assessment analysis

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

Correction to: Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

The original version of this article unfortunately contained a mistake

Prevalence, associated factors and outcomes of pressure injuries in adult intensive care unit patients: the DecubICUs study

Funder: European Society of Intensive Care Medicine; doi: http://dx.doi.org/10.13039/501100013347Funder: Flemish Society for Critical Care NursesAbstract: Purpose: Intensive care unit (ICU) patients are particularly susceptible to developing pressure injuries. Epidemiologic data is however unavailable. We aimed to provide an international picture of the extent of pressure injuries and factors associated with ICU-acquired pressure injuries in adult ICU patients. Methods: International 1-day point-prevalence study; follow-up for outcome assessment until hospital discharge (maximum 12 weeks). Factors associated with ICU-acquired pressure injury and hospital mortality were assessed by generalised linear mixed-effects regression analysis. Results: Data from 13,254 patients in 1117 ICUs (90 countries) revealed 6747 pressure injuries; 3997 (59.2%) were ICU-acquired. Overall prevalence was 26.6% (95% confidence interval [CI] 25.9–27.3). ICU-acquired prevalence was 16.2% (95% CI 15.6–16.8). Sacrum (37%) and heels (19.5%) were most affected. Factors independently associated with ICU-acquired pressure injuries were older age, male sex, being underweight, emergency surgery, higher Simplified Acute Physiology Score II, Braden score 3 days, comorbidities (chronic obstructive pulmonary disease, immunodeficiency), organ support (renal replacement, mechanical ventilation on ICU admission), and being in a low or lower-middle income-economy. Gradually increasing associations with mortality were identified for increasing severity of pressure injury: stage I (odds ratio [OR] 1.5; 95% CI 1.2–1.8), stage II (OR 1.6; 95% CI 1.4–1.9), and stage III or worse (OR 2.8; 95% CI 2.3–3.3). Conclusion: Pressure injuries are common in adult ICU patients. ICU-acquired pressure injuries are associated with mainly intrinsic factors and mortality. Optimal care standards, increased awareness, appropriate resource allocation, and further research into optimal prevention are pivotal to tackle this important patient safety threat

How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort

CatedresBackground: To estimate the prevalence and severity of menopausal symptoms and anxiety/depression and to assess the differences according to menopausal status among women living with HIV aged 45-60 years from the cohort of Spanish HIV/AIDS Research Network (CoRIS). Methods: Women were interviewed by phone between September 2017 and December 2018 to determine whether they had experienced menopausal symptoms and anxiety/depression. The Menopause Rating Scale was used to evaluate the prevalence and severity of symptoms related to menopause in three subscales: somatic, psychologic and urogenital; and the 4-item Patient Health Questionnaire was used for anxiety/depression. Logistic regression models were used to estimate odds ratios (ORs) of association between menopausal status, and other potential risk factors, the presence and severity of somatic, psychological and urogenital symptoms and of anxiety/depression. Results: Of 251 women included, 137 (54.6%) were post-, 70 (27.9%) peri- and 44 (17.5%) pre-menopausal, respectively. Median age of onset menopause was 48 years (IQR 45-50). The proportions of pre-, peri- and post-menopausal women who had experienced any menopausal symptoms were 45.5%, 60.0% and 66.4%, respectively. Both peri- and post-menopause were associated with a higher likelihood of having somatic symptoms (aOR 3.01; 95% CI 1.38-6.55 and 2.63; 1.44-4.81, respectively), while post-menopause increased the likelihood of having psychological (2.16; 1.13-4.14) and urogenital symptoms (2.54; 1.42-4.85). By other hand, post-menopausal women had a statistically significant five-fold increase in the likelihood of presenting severe urogenital symptoms than pre-menopausal women (4.90; 1.74-13.84). No significant differences by menopausal status were found for anxiety/depression. Joint/muscle problems, exhaustion and sleeping disorders were the most commonly reported symptoms among all women. Differences in the prevalences of vaginal dryness (p = 0.002), joint/muscle complaints (p = 0.032), and sweating/flush (p = 0.032) were found among the three groups. Conclusions: Women living with HIV experienced a wide variety of menopausal symptoms, some of them initiated before women had any menstrual irregularity. We found a higher likelihood of somatic symptoms in peri- and post-menopausal women, while a higher likelihood of psychological and urogenital symptoms was found in post-menopausal women. Most somatic symptoms were of low or moderate severity, probably due to the good clinical and immunological situation of these women